SEC Comment Letter 0000000000-24-011396 to CervoMed Inc. (CRVO)
CervoMed Inc.
Date: Oct. 8, 2024 · CIK: 0001053691 · Accession: 0000000000-24-011396
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-282494
Letter
October 8, 2024 John Alam, M.D. President and Chief Executive Officer CervoMed Inc. 20 Park Plaza, Suite 424 Boston, Massachusetts 02216 Re:CervoMed Inc. Registration Statement on Form S-3 Filed October 3, 2024 File No. 333-282494 Dear John Alam M.D.: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Jason S. McCaffrey, Esq.
Show Raw Text
October 8, 2024
John Alam, M.D.
President and Chief Executive Officer
CervoMed Inc.
20 Park Plaza, Suite 424
Boston, Massachusetts 02216
Re:CervoMed Inc.
Registration Statement on Form S-3
Filed October 3, 2024
File No. 333-282494
Dear John Alam M.D.:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at 202-551-6761 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Jason S. McCaffrey, Esq.